FGF21 and metabolic dysfunction-associated steatotic liver disease: In animal models of NASH, treatment with FGF21 reduces lipotoxicity and ameliorates liver injury38 while mice deficient in FGF21 are more prone to develop NAFLD on an obesogenic diet39.